Novo Holdings A/s
Novo Holdings A/s reported 27 stocks worth $1.5B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are EWTX (14.6%), ASML (11.6%) and BN (10.9%). Compared with Q2 2026, the fund opened new positions in OBX, SRRK and CTNM, added to BN, INSM and XENE and trimmed AVLN, FDMT and PCVX.
Latest filing: what Novo Holdings A/s did in Q3 2026
vs Q2 2026- Crinetics Pharmace$49.4M
Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() EWTX Edgewise Therapeutics Inc | $217M | 14.6% | 5.3M | No change | 8 of 8 | |
| 2 | ![]() ASML Asml Holding N V | $172M | 11.6% | 95K | No change | 8 of 8 | |
| 3 | ![]() BN Brookfield Corp Fclass A | $163M | 10.9% | 4.5M | +969K (+28%) | 8 of 8 | |
| 4 | ![]() COAG Hemab Therapeutics Hldgs Inc | $129M | 8.7% | 4.2M | No change | 2 of 8 | |
| 5 | ![]() AVLN Avalyn Pharma Inc | $98.3M | 6.6% | 3.4M | −434K (−11%) | 2 of 8 | |
| 6 | ![]() MIRM Mirum Pharmaceuticals Inc | $96.2M | 6.5% | 1.1M | No change | 8 of 8 | |
| 7 | ![]() CRM Salesforce Inc | $90.3M | 6.1% | 393K | No change | 8 of 8 | |
| 8 | ![]() ELVN Enliven Therapeutics Inc | $45.8M | 3.1% | 1M | No change | 6 of 8 | |
| 9 | ![]() FDMT 4D Molecular Therapeutics in | $42.9M | 2.9% | 3M | −249K (−8%) | 8 of 8 | |
| 10 | ![]() OBX Obsidian Therapeutics Inc | $42.9M | 2.9% | 3.1M | New position | 1 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
CRINETICS PHARMACEUTICALS IN | $49.4M | 1.3M |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Novo Holdings A/s 13F FAQ
What does Novo Holdings A/s own?
Novo Holdings A/s reported 27 stocks worth $1.5B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are EWTX (14.6%), ASML (11.6%) and BN (10.9%). The table above lists every position in the filing (the top 10 without an account).
What did Novo Holdings A/s buy and sell in Q3 2026?
Compared with Q2 2026: 3 new positions, 5 added to, 9 trimmed and 1 sold out. New positions include OBX, SRRK and CTNM.
When will Novo Holdings A/s file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Novo Holdings A/s's portfolio worth?
The Q3 2026 filing reports $1.5B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.



















